Build Your Comparison

Side-by-side financial analysis
NAKA logo
NAKA
UNH logo
UNH
CVS logo
CVS
TDOC logo
TDOC
Try popular comparisons:

Stock Comparison

NAKA vs UNH vs CVS vs TDOC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NAKA
Nakamoto Inc.

Financial - Capital Markets

Financial ServicesNASDAQ • US
Market Cap$79M
5Y Perf.-96.3%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$373.09B
5Y Perf.-17.0%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$128.46B
5Y Perf.+68.9%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.35B
5Y Perf.-33.6%

NAKA vs UNH vs CVS vs TDOC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NAKA logoNAKA
UNH logoUNH
CVS logoCVS
TDOC logoTDOC
IndustryFinancial - Capital MarketsMedical - Healthcare PlansMedical - Healthcare PlansMedical - Healthcare Information Services
Market Cap$79M$373.09B$128.46B$1.35B
Revenue (TTM)$4M$449.71B$407.90B$2.51B
Net Income (TTM)$-290M$12.04B$2.93B$-171M
Gross Margin-376.0%18.8%13.9%65.6%
Operating Margin-82.2%4.2%1.5%-7.6%
Forward P/E22.4x13.6x
Total Debt$210M$78.39B$93.59B$1.04B
Cash & Equiv.$23M$24.36B$8.51B$781M

NAKA vs UNH vs CVS vs TDOCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NAKA
UNH
CVS
TDOC
StockMay 24Jun 26Return
Nakamoto Inc. (NAKA)1003.7-96.3%
UnitedHealth Group … (UNH)10083.0-17.0%
CVS Health Corporat… (CVS)100168.9+68.9%
Teladoc Health, Inc. (TDOC)10066.4-33.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NAKA vs UNH vs CVS vs TDOC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. CVS Health Corporation is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇UNH emerged as the overall leader. Track its performance:
NAKA
Nakamoto Inc.
The Specific-Use Pick

NAKA plays a supporting role in this comparison — it may shine differently against other peers.

Best for: financial services exposure
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 241.6% 10Y total return vs CVS's 27.9%
  • 11.8% revenue growth vs NAKA's -33.0%
  • 2.7% margin vs NAKA's -74.0%
Best for: growth exposure and long-term compounding
CVS
CVS Health Corporation
The Insurance Pick

CVS is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 0 yrs, beta 0.19, yield 2.7%
  • Lower volatility, beta 0.19, current ratio 0.84x
  • Beta 0.19, yield 2.7%, current ratio 0.84x
  • Lower P/E (13.6x vs 22.4x)
Best for: income & stability and sleep-well-at-night
TDOC
Teladoc Health, Inc.
The Secondary Option

TDOC lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs NAKA's -33.0%
ValueCVS logoCVSLower P/E (13.6x vs 22.4x)
Quality / MarginsUNH logoUNH2.7% margin vs NAKA's -74.0%
Stability / SafetyCVS logoCVSBeta 0.19 vs NAKA's 2.88
DividendsUNH logoUNH2.1% yield, 16-year raise streak, vs CVS's 2.7%, (2 stocks pay no dividend)
Momentum (1Y)CVS logoCVS+52.6% vs NAKA's -99.3%
Efficiency (ROA)UNH logoUNH3.9% ROA vs NAKA's -56.5%, ROIC 9.2% vs -42.1%

NAKA vs UNH vs CVS vs TDOC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Biotech & Healthcare Stocks Theme

These companies are key players in the Biotech & Healthcare Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
NAKANakamoto Inc.
FY 2025
Product Retail Sales
100.0%$1,479
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M

NAKA vs UNH vs CVS vs TDOC — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCVSLAGGINGTDOC

Income & Cash Flow (Last 12 Months)

Evenly matched — UNH and TDOC each lead in 2 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 114732.7x NAKA's $4M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to NAKA's -74.0%. On growth, NAKA holds the edge at +3.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
RevenueTrailing 12 months$4M$449.7B$407.9B$2.5B
EBITDAEarnings before interest/tax-$320M$23.2B$10.5B$42M
Net IncomeAfter-tax profit-$290M$12.0B$2.9B-$171M
Free Cash FlowCash after capex-$46M$19.7B$7.4B$251M
Gross MarginGross profit ÷ Revenue-3.8%+18.8%+13.9%+65.6%
Operating MarginEBIT ÷ Revenue-82.2%+4.2%+1.5%-7.6%
Net MarginNet income ÷ Revenue-74.0%+2.7%+0.7%-6.8%
FCF MarginFCF ÷ Revenue-11.7%+4.4%+1.8%+10.0%
Rev. Growth (YoY)Latest quarter vs prior year+3.6%+2.0%+6.2%-2.5%
EPS Growth (YoY)Latest quarter vs prior year-88.4%+0.7%+63.1%+32.1%
Evenly matched — UNH and TDOC each lead in 2 of 6 comparable metrics.

Valuation Metrics

CVS leads this category, winning 3 of 6 comparable metrics.

At 31.1x trailing earnings, UNH trades at a 57% valuation discount to CVS's 72.4x P/E. On an enterprise value basis, CVS's 14.2x EV/EBITDA is more attractive than UNH's 18.3x.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
Market CapShares × price$79M$373.1B$128.5B$1.3B
Enterprise ValueMkt cap + debt − cash$266M$427.1B$213.5B$1.6B
Trailing P/EPrice ÷ TTM EPS-0.43x31.07x72.43x-6.54x
Forward P/EPrice ÷ next-FY EPS est.22.35x13.61x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple18.31x14.24x16.02x
Price / SalesMarket cap ÷ Revenue43.19x0.83x0.32x0.53x
Price / BookPrice ÷ Book value/share0.10x3.68x1.70x0.95x
Price / FCFMarket cap ÷ FCF23.21x16.45x4.72x
CVS leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

UNH leads this category, winning 6 of 9 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-85 for NAKA. NAKA carries lower financial leverage with a 0.41x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs NAKA's 2/9, reflecting solid financial health.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
ROE (TTM)Return on equity-84.8%+11.5%+3.9%-12.4%
ROA (TTM)Return on assets-56.5%+3.9%+1.1%-5.9%
ROICReturn on invested capital-42.1%+9.2%+5.0%-11.5%
ROCEReturn on capital employed-76.2%+9.7%+6.1%-10.0%
Piotroski ScoreFundamental quality 0–92656
Debt / EquityFinancial leverage0.41x0.77x1.24x0.75x
Net DebtTotal debt minus cash$187M$54.0B$85.1B$259M
Cash & Equiv.Liquid assets$23M$24.4B$8.5B$781M
Total DebtShort + long-term debt$210M$78.4B$93.6B$1.0B
Interest CoverageEBIT ÷ Interest expense-24.72x4.71x2.11x-8.76x
UNH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CVS leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in CVS five years ago would be worth $13,226 today (with dividends reinvested), compared to $374 for NAKA. Over the past 12 months, CVS leads with a +52.6% total return vs NAKA's -99.3%. The 3-year compound annual growth rate (CAGR) favors CVS at 16.0% vs NAKA's -66.6% — a key indicator of consistent wealth creation.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
YTD ReturnYear-to-date-72.3%+23.5%+27.3%+5.8%
1-Year ReturnPast 12 months-99.3%+37.2%+52.6%+6.3%
3-Year ReturnCumulative with dividends-96.3%-6.0%+56.2%-70.4%
5-Year ReturnCumulative with dividends-96.3%+12.6%+32.3%-95.1%
10-Year ReturnCumulative with dividends-96.3%+241.6%+27.9%-42.8%
CAGR (3Y)Annualised 3-year return-66.6%-2.0%+16.0%-33.4%
CVS leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

CVS is the less volatile stock with a 0.19 beta — it tends to amplify market swings less than NAKA's 2.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 98.8% from its 52-week high vs NAKA's 0.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
Beta (5Y)Sensitivity to S&P 5002.88x0.61x0.19x1.85x
52-Week HighHighest price in past year$679.20$415.96$102.77$9.77
52-Week LowLowest price in past year$0.38$234.60$58.50$4.40
% of 52W HighCurrent price vs 52-week peak+0.7%+98.8%+98.0%+76.4%
RSI (14)Momentum oscillator 0–10035.467.974.759.0
Avg Volume (50D)Average daily shares traded274K7.2M7.5M4.4M
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.

Analyst consensus: NAKA as "Buy", UNH as "Buy", CVS as "Buy", TDOC as "Hold". Consensus price targets imply 77.0% upside for NAKA (target: $8) vs -0.8% for TDOC (target: $7). For income investors, CVS offers the higher dividend yield at 2.65% vs UNH's 2.12%.

MetricNAKA logoNAKANakamoto Inc.UNH logoUNHUnitedHealth Grou…CVS logoCVSCVS Health Corpor…TDOC logoTDOCTeladoc Health, I…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHold
Price TargetConsensus 12-month target$8.00$418.50$103.64$7.40
# AnalystsCovering analysts2524142
Dividend YieldAnnual dividend ÷ price+2.1%+2.7%
Dividend StreakConsecutive years of raises0160
Dividend / ShareAnnual DPS$8.70$2.67
Buyback YieldShare repurchases ÷ mkt cap+0.4%+1.5%0.0%0.0%
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Key Takeaway

CVS leads in 2 of 6 categories (Valuation Metrics, Total Returns). UNH leads in 1 (Profitability & Efficiency). 3 tied.

Best OverallCVS Health Corporation (CVS)Leads 2 of 6 categories
Loading custom metrics...

NAKA vs UNH vs CVS vs TDOC: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NAKA or UNH or CVS or TDOC a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus -33. 0% for Nakamoto Inc. (NAKA). UnitedHealth Group Incorporated (UNH) offers the better valuation at 31. 1x trailing P/E (22. 4x forward), making it the more compelling value choice. Analysts rate Nakamoto Inc. (NAKA) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NAKA or UNH or CVS or TDOC?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 31.

1x versus CVS Health Corporation at 72. 4x. On forward P/E, CVS Health Corporation is actually cheaper at 13. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — NAKA or UNH or CVS or TDOC?

Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +32.

3%, compared to -96. 3% for Nakamoto Inc. (NAKA). Over 10 years, the gap is even starker: UNH returned +241. 6% versus NAKA's -96. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NAKA or UNH or CVS or TDOC?

By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.

19β versus Nakamoto Inc. 's 2. 88β — meaning NAKA is approximately 1411% more volatile than CVS relative to the S&P 500. On balance sheet safety, Nakamoto Inc. (NAKA) carries a lower debt/equity ratio of 41% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — NAKA or UNH or CVS or TDOC?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus -33. 0% for Nakamoto Inc. (NAKA). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -1452. 2% for Nakamoto Inc.. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NAKA or UNH or CVS or TDOC?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -28. 7% for Nakamoto Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -108. 2% for NAKA. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NAKA or UNH or CVS or TDOC more undervalued right now?

On forward earnings alone, CVS Health Corporation (CVS) trades at 13.

6x forward P/E versus 22. 4x for UnitedHealth Group Incorporated — 8. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NAKA: 77. 0% to $8. 00.

08

Which pays a better dividend — NAKA or UNH or CVS or TDOC?

In this comparison, CVS (2.

7% yield), UNH (2. 1% yield) pay a dividend. NAKA, TDOC do not pay a meaningful dividend and should not be held primarily for income.

09

Is NAKA or UNH or CVS or TDOC better for a retirement portfolio?

For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

19), 2. 7% yield). Nakamoto Inc. (NAKA) carries a higher beta of 2. 88 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +27. 9%, NAKA: -96. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NAKA and UNH and CVS and TDOC?

These companies operate in different sectors (NAKA (Financial Services) and UNH (Healthcare) and CVS (Healthcare) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

UNH, CVS pay a dividend while NAKA, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.